Summit Trail Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
2,649
+992
+60% +$508K 0.02% 817
2025
Q4
$931K Buy
1,657
+792
+92% +$450K 0.02% 851
2025
Q3
$445K Buy
+865
New +$378K 0.01% 1111

Other funds holding MEDP

Summit Trail Advisors's MEDP Position: Q1 2026 in Review

Summit Trail Advisors increased its Medpace (MEDP) stake by 60% in Q1 2026, buying an estimated $508K and bringing the position to 2,649 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #817.

Summit Trail Advisors first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Summit Trail Advisors held 2,649 shares of Medpace worth $1.27M as of Q1 2026.
  • Summit Trail Advisors bought 992 Medpace shares in Q1 2026, an estimated $508K.
  • Medpace made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #817 holding.
  • Summit Trail Advisors first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.